A phase Ib study of oxaliplatin in combination with fluorouracil (5FU) and leucovorin (LV) in pediatric patients (pts) with advanced solid tumors

被引：0
|
作者：
Gore, L.
Kuttesch, J.
Hunger, S. P.
Herzog, C.
Narendaren, A.
Boklan, J.
Foreman, N. K.
Ivy, S. P.
Boucher, N.
Trippett, T. M.
机构：
[1] UCHSC Fitzsimons, Aurora, CO USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Univ Florida, Shands Canc Ctr, Gainesville, FL USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Calgary, Alberta Childrens Hosp, Calgary, AB, Canada
[6] Phoenix Childrens Hosp, Phoenix, AZ USA
[7] NCI, Rockville, MD USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9548
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors
    Macy, Margaret E.
    Duncan, Tracey
    Whitlock, James
    Hunger, Stephen P.
    Boklan, Jessica
    Narendren, Aru
    Herzog, Cynthia
    Arceci, Robert J.
    Bagatell, Rochelle
    Trippett, Tanya
    Christians, Uwe
    Rolla, Katherine
    Ivy, S. Percy
    Gore, Lia
    PEDIATRIC BLOOD & CANCER, 2013, 60 (02) : 230 - 236
  • [2] Oxaliplatin (L-OHP) in combination with leucovorin (LV) and 5-fluorouracil (5FU) in pretreated metastatic colorectal cancer (CRC) patients (PTS).
    Di Stefano, A
    Calandri, C
    Benedetti, G
    Poggi, B
    Mazzoni, F
    Marrocolo, F
    Spagnuolo, P
    Rimondini, S
    Crinò, L
    ANNALS OF ONCOLOGY, 2000, 11 : 68 - 68
  • [3] A phase I study of ZD 1839 (Iressa) in combination with oxaliplatin, 5-fluorouracil (5-FU) and leucovorin (LV) in advanced solid malignancies
    Fisher, GA
    Cho, CD
    Halsey, JZ
    Advani, RH
    Yuen, AR
    Lum, BL
    Sikic, BI
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S63 - S63
  • [4] Phase I study of oxaliplatin in combination with 5-fluorouracil (5-FU), leucovorin (LV) and capecitabine (ORAL FOLFOX-6) in patients with advanced or metastatic solid tumors.
    Hegeman, RB
    Mulkerin, D
    Thomas, J
    Alberti, D
    Binger, K
    Marnocha, R
    Kolesar, J
    Wilding, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 149S - 149S
  • [5] A phase I study of bortezomib in combination with 5FU/LV plus oxaliplatin in patients (pts) with advanced colorectal cancer (CRC): EORTC 16029
    Lacombe, D. A.
    Caponigro, F.
    Anthoney, A.
    Bauer, J.
    Govaerts, A.
    Milano, A.
    Marreaud, S.
    Twelves, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Proteomics analysis of the effect of fluorouracil (5FU) and 5FU/leucovorin (LV) on colorectal cancer (CRC) in patients
    Smid, Kees
    Meijer, Erik
    Pham, Thang V.
    de Reus, Inge
    Piersma, Sander R.
    Peters, Godefridus J.
    Jimenez, Connie R.
    CANCER RESEARCH, 2015, 75
  • [7] Bi-fractionated oxaliplatin (L-OHP) plus 5-fluorouracil (5FU)/leucovorin (LV) for elderly patients (pts) with advanced colorectal cancer (CRC).
    Massacesi, C
    Lippe, P
    Recchia, F
    Marcucci, F
    Rocchi, M
    Cesta, A
    Pilone, A
    Cappelletti, C
    Bonsignori, M
    Mattioli, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 275S - 275S
  • [8] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in previously treated patients with advanced metastatic gastric cancer
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Anselmi, E
    Bidin, L
    Palladino, M
    Rodinò, C
    ANNALS OF ONCOLOGY, 2005, 16 : 323 - 323
  • [9] Phase I Study of Flavopiridol with Oxaliplatin and Fluorouracil/Leucovorin in Advanced Solid Tumors
    Rathkopf, Dana
    Dickson, Mark A.
    Feldman, Darren R.
    Carvajal, Richard D.
    Shah, Manish A.
    Wu, Nian
    Lefkowitz, Robert
    Gonen, Mithat
    Cane, Lauren M.
    Dials, Heather J.
    Winkelmann, Jennifer L.
    Bosl, George J.
    Schwartz, Gary K.
    CLINICAL CANCER RESEARCH, 2009, 15 (23) : 7405 - 7411
  • [10] A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.
    Gong, Jifang
    Deng, Ting
    Li, Jie
    Lu, Ming
    Li, Jian
    Ba, Yi
    Yu, Qiuqiong
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345